Stock Scorecard



Stock Summary for Certara Inc (CERT) - $12.93 as of 10/8/2025 3:52:08 PM EST

Total Score

9 out of 30

Safety Score

37 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for CERT

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for CERT

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for CERT

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for CERT

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for CERT (37 out of 100)

Stock Price Rating (Max of 10) 5
Historical Stock Price Rating (Max of 10) 7
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 4
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 3
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 2
Trading Volume (Max of 10) 9
Price to Earnings (Max of 10) 1
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for CERT

Can Doximity's New AI Suite Drive the Growth It Needs? 10/2/2025 1:13:00 PM
RH Posts Downbeat Results, Joins Frequency Electronics, Tronox And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Certara ( NASDAQ:CERT ) , Abivax ( NASDAQ:ABVX ) 9/12/2025 12:24:00 PM
Certara to Participate in Upcoming Investor Conferences 9/2/2025 8:15:00 PM
Certara to Participate in Upcoming Investor Conferences - Certara ( NASDAQ:CERT ) 9/2/2025 8:15:00 PM
Certara ( CERT ) Q2 Revenue Jumps 12% 8/7/2025 1:13:00 AM
Certara, Inc. ( CERT ) Q2 Earnings Miss Estimates 8/6/2025 10:00:00 PM
Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling 8/4/2025 6:00:00 AM
Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling - Certara ( NASDAQ:CERT ) 8/4/2025 6:00:00 AM
Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform 7/31/2025 8:15:00 PM
Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform - Certara ( NASDAQ:CERT ) 7/31/2025 8:15:00 PM

Financial Details for CERT

Company Overview

Ticker CERT
Company Name Certara Inc
Country USA
Description Certara Inc. (CERT) is a leading provider of biosimulation software and technology services that enhance drug discovery, preclinical and clinical research, and regulatory compliance. Headquartered in Princeton, New Jersey, the company leverages advanced modeling and simulation techniques to streamline the drug development process, supporting pharmaceutical companies in making informed decisions and achieving faster market access. With a strong focus on innovation, Certara aims to improve patient outcomes by optimizing drug development pathways through its cutting-edge solutions.
Sector Name HEALTHCARE
Industry Name HEALTH INFORMATION SERVICES
Most Recent Quarter 6/30/2025
Next Earnings Date 11/5/2025

Stock Price History

Last Day Price 12.93
Price 4 Years Ago 28.42
Last Day Price Updated 10/8/2025 3:52:08 PM EST
Last Day Volume 1,618,683
Average Daily Volume 1,800,255
52-Week High 15.69
52-Week Low 8.63
Last Price to 52 Week Low 49.83%

Valuation Measures

Trailing PE 261.40
Industry PE 85.75
Sector PE 41.70
5-Year Average PE 74.30
Free Cash Flow Ratio 12.80
Industry Free Cash Flow Ratio 22.37
Sector Free Cash Flow Ratio 30.25
Current Ratio Most Recent Quarter 2.16
Total Cash Per Share 1.01
Book Value Per Share Most Recent Quarter 6.67
Price to Book Ratio 2.04
Industry Price to Book Ratio 4.80
Sector Price to Book Ratio 32.02
Price to Sales Ratio Twelve Trailing Months 5.17
Industry Price to Sales Ratio Twelve Trailing Months 5.64
Sector Price to Sales Ratio Twelve Trailing Months 20.22
Analyst Buy Ratings 5
Analyst Strong Buy Ratings 1

Share Statistics

Total Shares Outstanding 160,624,000
Market Capitalization 2,076,868,320
Institutional Ownership 104.23%

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY -14.10%
Annual Earnings Growth 78.23%
Reported EPS 12 Trailing Months 0.05
Reported EPS Past Year 0.10
Reported EPS Prior Year 0.45
Net Income Twelve Trailing Months 7,981,000
Net Income Past Year -12,051,000
Net Income Prior Year -55,357,000
Quarterly Revenue Growth YOY 12.10%
5-Year Revenue Growth 13.06%
Operating Margin Twelve Trailing Months 4.97%

Balance Sheet

Total Cash Most Recent Quarter 162,266,000
Total Cash Past Year 179,183,000
Total Cash Prior Year 234,951,000
Net Cash Position Most Recent Quarter -128,904,000
Net Cash Position Past Year -113,242,000
Long Term Debt Past Year 292,425,000
Long Term Debt Prior Year 288,217,000
Total Debt Most Recent Quarter 291,170,000
Equity to Debt Ratio Past Year 0.78
Equity to Debt Ratio Most Recent Quarter 0.79
Total Stockholder Equity Past Year 1,058,656,000
Total Stockholder Equity Prior Year 1,046,839,999
Total Stockholder Equity Most Recent Quarter 1,070,579,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 86,563,000
Free Cash Flow Per Share Twelve Trailing Months 0.54
Free Cash Flow Past Year 78,841,000
Free Cash Flow Prior Year 67,433,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.56
MACD Signal 0.37
20-Day Bollinger Lower Band 9.55
20-Day Bollinger Middle Band 11.25
20-Day Bollinger Upper Band 12.96
Beta 1.45
RSI 65.17
50-Day SMA 11.54
150-Day SMA 15.06
200-Day SMA 16.30

System

Modified 10/6/2025 8:11:27 PM EST